CSI Market
Sign In | Register

Moonlake Immunotherapeutics (MLTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MLTX Annual Balance Sheets →
Quarterly balance sheet trends provide context on Moonlake Immunotherapeutics's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent537.00
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments537.00
Other Receivables, Net, Current6.56
Other Current Assets0.00
Prepaid Expense, Current AS26.45
Total Current Assets570.04
Equipment/Property/Plant Net0.49
Prepaid Expense, Noncurrent, Total PR1.34
Other Assets, Noncurrent2.11
Operating Lease Right Of Use Asset1.86
Total Assets573.95
Liabilities
Accrued Liabilities And Other Liabilities2.61
Other Liabilities, Current40.43
Taxes Payable2.35
Total Current Liabilities45.39
Long-term debt99.51
Total Long-term Debt99.51
Defined Benefit Pension Plan, Liabilities, Noncurrent PE0.07
Other liabilities, Noncurrent0.77
Operating Lease Liability Current0.92
Operating Lease Liability Noncurrent0.87
Total Liabilities145.75
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,021.98
Retained Earnings / Accumulated Deficit-594.42
Accumulated Other Comprehensive Income0.63
Other Equity0.63
Common Stockholder's Equity428.20
Non-controlling interests & other0.00
Total Stockholder's Equity428.20
Liabilities & Stockholder's Equity573.95
4 historic quarters locked

Sign in to unlock the full Moonlake Immunotherapeutics balance sheet history.

Sign In Create Free Account

About Moonlake Immunotherapeutics Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001821586-26-000010

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.